Analysen von Michael Leuchten
| 28.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 24.08.23 | Roche Neutral | UBS AG | |
| 01.08.23 | Sanofi Neutral | UBS AG | |
| 18.07.23 | Novartis Neutral | UBS AG | |
| 04.07.23 | AstraZeneca Neutral | UBS AG | |
| 19.06.23 | AstraZeneca Neutral | UBS AG | |
| 15.06.23 | Roche Neutral | UBS AG | |
| 15.06.23 | Novartis Neutral | UBS AG | |
|
Werbung
|
|||
| 13.06.23 | Sanofi Neutral | UBS AG | |
| 05.06.23 | AstraZeneca Neutral | UBS AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 22.05.23 | Sanofi Neutral | UBS AG | |
| 18.05.23 | AstraZeneca Neutral | UBS AG | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 27.04.23 | AstraZeneca Neutral | UBS AG | |
| 27.04.23 | Sanofi Neutral | UBS AG | |
| 30.03.23 | Sanofi Neutral | UBS AG | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 23.03.23 | Sanofi Neutral | UBS AG | |
| 14.03.23 | Sanofi Neutral | UBS AG | |
| 10.03.23 | AstraZeneca Neutral | UBS AG | |
| 03.03.23 | Roche Neutral | UBS AG | |
| 21.02.23 | AstraZeneca Neutral | UBS AG | |
| 10.02.23 | AstraZeneca Neutral | UBS AG | |
| 07.02.23 | Roche Neutral | UBS AG | |
| 06.02.23 | Sanofi Neutral | UBS AG | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 20.01.23 | Roche Neutral | UBS AG | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 09.01.23 | Sanofi Neutral | UBS AG | |
| 09.01.23 | Roche Neutral | UBS AG | |
| 09.01.23 | Novartis Neutral | UBS AG | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 14.12.22 | Roche Neutral | UBS AG | |
| 14.12.22 | Sanofi Neutral | UBS AG | |
| 12.12.22 | Sanofi Neutral | UBS AG | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 01.12.22 | Sanofi Neutral | UBS AG | |
| 21.11.22 | Sanofi Neutral | UBS AG | |
| 14.11.22 | Roche Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | Merck Neutral | UBS AG | |
| 02.11.22 | GSK Neutral | UBS AG | |
| 28.10.22 | Sanofi Neutral | UBS AG | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 21.10.22 | GSK Neutral | UBS AG | |
| 18.10.22 | Roche Neutral | UBS AG | |
| 13.10.22 | GSK Neutral | UBS AG | |
| 29.09.22 | Roche Neutral | UBS AG | |
| 26.09.22 | Novartis Neutral | UBS AG | |